1. Home
  2. ANNX vs OXM Comparison

ANNX vs OXM Comparison

Compare ANNX & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.77

Market Cap

812.7M

Sector

Health Care

ML Signal

HOLD

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

HOLD

Current Price

$36.69

Market Cap

675.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
OXM
Founded
2011
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
812.7M
675.3M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ANNX
OXM
Price
$5.77
$36.69
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$16.50
$38.00
AVG Volume (30 Days)
4.4M
618.8K
Earning Date
05-11-2026
06-10-2026
Dividend Yield
N/A
6.80%
EPS Growth
N/A
N/A
EPS
N/A
1.00
Revenue
N/A
$1,477,834,000.00
Revenue This Year
N/A
$2.85
Revenue Next Year
$16,320.74
$2.63
P/E Ratio
N/A
$36.99
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$30.57
52 Week High
$7.18
$51.61

Technical Indicators

Market Signals
Indicator
ANNX
OXM
Relative Strength Index (RSI) 55.54 47.92
Support Level $4.75 $34.86
Resistance Level $5.89 $42.12
Average True Range (ATR) 0.42 1.91
MACD 0.08 0.31
Stochastic Oscillator 54.60 61.96

Price Performance

Historical Comparison
ANNX
OXM

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.

Share on Social Networks: